President’s Message

On behalf of Israel Cancer Research Fund (ICRF) and its Board of Directors, I would like to thank everyone who has supported us throughout the years as well as contributed to the success of all of our events. This support has allowed us to meet our financial goals and support such worthwhile cancer research projects both in Israel and locally here in Montreal. Whether or not someone has been personally affected by cancer, the search for a cure is a cause that we all can contribute to.

As President, I want to share how truly appreciative I am of all the efforts made throughout the year and how enjoyable it is to be part of a dedicated and enthusiastic group of volunteers that make up ICRF today. It is clear that there are increasingly many more draws for one’s time and money from many worthy causes and charities. ICRF is fortunate to have such a strong and supportive community of people and companies that generously push towards our common goals. For me, working as part of this group is a real honour.

ICRF’s fund raising efforts have contributed to many successful projects over the past 35 plus years. One of the measurable successes of our efforts was when the Nobel Prize for Chemistry was awarded to Dr. Avrum Hershko and Dr. Aaron Ciechanover in 2004, two Israeli scientists whose research has been supported by ICRF for more than twenty years. Their discovery of a process that lets cells destroy unwanted proteins, called the ubiquitin system, led to a groundbreaking new treatment for multiple myeloma, a cancer of the bone marrow. The development of the drug Velcade, which the FDA termed “the first in a new class of anticancer agents” was the result.

We encourage everyone to join us in the fight against cancer and look forward to seeing you at our upcoming ICRF events.

Once again, thank you for your support. Without it, ICRF could not continue its fight against cancer.

With sincere appreciation,

Jeffrey Bernstein